Hou et al. reported Gal alleviated I/R-induced cardiac dysfunction, reduced ERS-related apoptosis, and inhibited myocardial fibrosis by suppressing AMPK/Nrf2 pathways (239). This evidence concerns the gene PRKAA1 and Myocardial fibrosis.